Phlow, a public benefit corporation on a mission to ensure a reliable supply of medicines essential for pediatric care, is proud to partner with OrbitalRX and its one-of-a-kind drug shortage management platform. OrbitalRX is designed by pharmacists, for pharmacists to help hospitals combine internal and external data to better anticipate, evaluate, and take action before drug shortages become a problem. By leveraging OrbitalRX’s data-unifying platform, hospitals can now respond more effectively to supply chain threats and ensure the appropriate level of care is available for their patients.
OrbitalRX recognized that some of the existing tools available to hospitals were siloed, inefficient, and lacked transparency. OrbitalRx took action, by developing a single platform that empowers pharmacy leaders to begin automating medication shortage management workflows. “Phlow is proud to partner with OrbitalRX on the joint mission of improving patient health by helping hospitals more effectively manage their pharmaceutical supply chains by providing integrated, real-time situational awareness that can lead to more effective and efficient actions. Together, we can help stabilize the health of our nation by improving the reliability of our supply chain,” said Dan Hackman, President of Phlow.
“As pharmacists, Nate and I are very familiar with the strain drug shortages put on hospital pharmacies and, ultimately, patient care,” said Adam Orsborn PharmD, MS, CEO of OrbitalRX. “We knew we could effect change and that building our platform was the first step in transforming how drug supply disruptions are managed. Partnering with innovative solution providers, like Phlow, allows us to further our vision and deliver even more transparency and insight through the drug supply chain solutions we’re building together for health systems.”